Small group conversations with payers, administrators, and other key decision-makers on issues relating to practice and policy.
June 15th 2024Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
Ryan Haumschild, PharmD, MBA, leads a discussion with Heidi Crayton, MD, and Maria Lopes, MD, on the current treatment landscape for multiple sclerosis, novel therapies, step therapy, and guidelines for disease management.
June 4th 2024Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access
Casey Butrus, PharmD; Michael Cameron, MD, FAAD, and Brittany Craiglow, MD, explore the advancement of topical treatments and treatment sequencing for atopic dermatitis (AD), while also providing valuable insights from the payer's perspective.
August 21st 2023Respiratory Syncytial Virus (RSV) in Infants and Children
Experts discuss financial considerations driving RSV treatment in pediatric patients.
October 31st 2022Payer Perspectives in Major Depressive Disorder (MDD)
Expert panelists provide payer considerations pertaining to the treatment of MDD.